The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity
Abstract
Abstract— This study was designed to determine the role of changes in adrenergic activity in mediating the chronic cardiovascular, renal, and metabolic actions of leptin. Male Sprague-Dawley rats were implanted with catheters for mean arterial pressure (MAP) and heart rate (HR) measurements and IV infusions of either vehicle (n= 7) or α- and β-adrenergic receptor antagonists, terazosin and propranolol (10 mg/kg/d; n= 8) throughout the study. After control measurements, murine leptin was infused IV (1.0 μg/kg/min) for 7 days along with vehicle or adrenergic antagonists, followed by a 7-day recovery period. Leptin infusion significantly reduced food intake in control rats from 22.6±0.8 to 10.6±0.4 g/d and, in adrenergic blockade rats, from 22.6±0.8 to 13.2±0.8 g/d. Fasting plasma insulin decreased from 48±10 to 5±2 μU/mL in control rats and from 51±9 to 9±2 μU/mL in adrenergic blockade rats during leptin infusion. Leptin infusion did not significantly alter glomerular filtration rate in either group. MAP and HR increased by 6±1 mm Hg and 23±7 bpm after 7 days of leptin infusion in control rats. However, in adrenergic blockade rats, leptin infusion did not significantly alter MAP (−1±1 mm Hg) and decreased, rather than increased, HR (−23±8 bpm). These results indicate that leptin-induced increases in blood pressure and tachycardia are mediated by increased adrenergic activity and support the concept that leptin may be an important link between obesity, increased sympathetic activity, and hypertension. However, the chronic effects of leptin on insulin and glucose regulation do not appear to be altered by α- and β-adrenergic receptor blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Combined blockade of both a-adrenergic and β-adrenergic receptors abolished the chronic effects of leptin on BP in male rats, suggesting that these effects were mediated by the SNS128.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [128]
In the citing paper
“administration of α/β-adrenergic blockers or clonidine, which stimulates central α-2 adrenergic receptors and reduces SNS activity, prevents most of the obesity-induced rise in BP in obese animals10,62 and α/β-adrenergic blockade reduces ambulatory BP significantly more in obese than in lean hypertensive patients63”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [62]
In the citing paper
“The BP effects of leptin were completely abolished by combined α/β-adrenergic receptor blockade”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [62]
In the citing paper
“Leptin requires activation of POMC neurons and MC4R to mediate its effects on renal SNS activity and BP [28, 50, 51].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Receptor-mediated regional sympathetic nerve activation by leptin.
Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L., & Sivitz, W. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119532 · Cited by 979
Diet-induced obese mice develop peripheral, but not central, resistance to leptin.
van Heek, M., Compton, D. S., France, C. F., Tedesco, R. P., Fawzi, A. B., Graziano, M. P., Sybertz, E. J., Strader, C. D., & Davis, H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119171 · Cited by 765
Chronic Leptin Infusion Increases Arterial Pressure
Shek, E. W., Brands, M. W., & Hall, J. E. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.409 · Cited by 686
Self-citationPathophysiological role of leptin in obesity-related hypertension
Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., Matsuoka, N., Hayashi, T., Hosoda, K., Inoue, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8341 · Cited by 477
Obesity hypertension: role of leptin and sympathetic nervous system
Hall, J. E. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02077-5 · Cited by 361
Self-citationSympathetic and Cardiorenal Actions of Leptin
Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., & Mark, A. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.619 · Cited by 351
Leptin Receptors Expressed on Pancreatic β-Cells
Kieffer, T. J., Heller, R. S., & Habener, J. F. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1059 · Cited by 326
Pivotal role of nitric oxide in the control of blood pressure after leptin administration.
Frühbeck, G. (1999) · Diabetes · doi:10.2337/diabetes.48.4.903 · Cited by 319
Landsberg, L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103001-00001 · Cited by 312
Renal Denervation Attenuates the Sodium Retention and Hypertension Associated With Obesity
Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., & Granger, J. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.893 · Cited by 307
Self-citation
Research works printed but not linked: 7
- 10.1161/hyp.33.1.548 · DOI
- 10.1161/hyp.25.4.893 · DOI
- 10.1161/hyp.30.3.619 · DOI
- 10.1161/hyp.31.1.409 · DOI
- 10.1161/hyp.37.3.936 · DOI
- 10.1161/hyp.37.2.670 · DOI
- Correia M, Mark AL, Morgan DA, Rahmouni K, Haynes WG. A new concept of selective leptin resistance: evidence from Agouti Yellow obese mice. J Hypertens. 2001; 19 (suppl 2): s95 (abstract).
Cited by
Sorted by citations
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedObesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Self-citationThe Kidney, Hypertension, and Obesity
Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868
Self-citationObesity-Associated Hypertension
Rahmouni, K., Correia, M., Haynes, W. G., & Mark, A. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 788
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
Self-citationObesity, Sleep Apnea, and Hypertension
Wolk, R., Shamsuzzaman, A. S. M., & Somers, V. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000101686.98973.a3 · Cited by 532
Leptin and Cardiovascular Disease
Koh, K. K., Park, S. M., & Quon, M. J. (2008) · Circulation · doi:10.1161/circulationaha.107.741645 · Cited by 481
Mechanisms of Obesity-Associated Cardiovascular and Renal Disease
Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., & Dubbert, P. M. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200209000-00003 · Cited by 373
Self-citationRole of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.066 · Cited by 392
Self-citationLeptin Mediates the Increase in Blood Pressure Associated with Obesity
Simonds, S. E., Pryor, J. T., Ravussin, É., Greenway, F. L., Dileone, R., Allen, A. M., Bassi, J. K., Elmquist, J. K., Keogh, J. M., Henning, E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.058 · Cited by 352
Assessment of Sympathetic Cardiovascular Drive in Human Hypertension
Grassi, G. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119883 · Cited by 340
Yang, R., & Barouch, L. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.156596 · Cited by 334
Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension
Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., & Haynes, W. G. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2012 · Cited by 319
Metabolic syndrome and chronic kidney disease
Singh, A. K., & Kari, J. A. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835dda78 · Cited by 299
Rodent models of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001941 · Cited by 288
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
Hall, J. E., Mouton, A. J., da Silva, A. A., Omoto, A. C. M., Wang, Z., Li, X., & do Carmo, J. M. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa336 · Cited by 290
Self-citationIs obesity a major cause of chronic kidney disease?
Hall, J. E., Henegar, J. R., Dwyer, T. M., Liu, J., da Silva, A. A., Kuo, J. J., & Tallam, L. (2004) · Advances in Renal Replacement Therapy · doi:10.1053/j.arrt.2003.10.007 · Cited by 264
Self-citationCastrop, H., Höcherl, K., Kurtz, A., Schweda, F., Todorov, V., & Wagner, C. (2010) · Physiological Reviews · doi:10.1152/physrev.00011.2009 · Cited by 265
Sympathetic system activity in obesity and metabolic syndrome
TENTOLOURIS, N., LIATIS, S., & KATSILAMBROS, N. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.010 · Cited by 260
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Self-citationSympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications
Kalil, G. Z., & Haynes, W. G. (2011) · Hypertension Research · doi:10.1038/hr.2011.173 · Cited by 234
Role of leptin in blood pressure regulation and arterial hypertension
Bełtowski, J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222743.06584.66 · Cited by 220
Autonomic imbalance: prophet of doom or scope for hope?
Vinik, A. I., Maser, R. E., & Ziegler, D. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03184.x · Cited by 209
The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
Xia, N., & Li, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13650 · Cited by 206
Differential Role of Leptin and Adiponectin in Cardiovascular System
Ghantous, C. M., Azrak, Z., Hanache, S., Abou-Kheir, W. G., & Zeidan, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/534320 · Cited by 211
Mechanisms of endothelial dysfunction in obesity.
Avogaro, A., & de Kreutzenberg, S. V. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.020 · Cited by 188
Masuyama, H., & Hiramatsu, Y. (2012) · Endocrinology · doi:10.1210/en.2011-2161 · Cited by 212
Obesity-associated hypertension and kidney disease
Hall, J. E., Kuo, J. J., da Silva, A. A., de Paula, R. B., Liu, J., & Tallam, L. (2003) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200303000-00011 · Cited by 187
Self-citationHypothalamic Arcuate Nucleus Mediates the Sympathetic and Arterial Pressure Responses to Leptin
Rahmouni, K., & Morgan, D. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000254827.59792.b2 · Cited by 178
The metabolic syndrome and chronic kidney disease
Zhang, X., & Lerman, L. O. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.004 · Cited by 185
Role of Leptin in Cardiovascular Diseases
Poetsch, M. S., Strano, A., & Guan, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00354 · Cited by 191
Selective leptin resistance revisited
Mark, A. L. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00180.2013 · Cited by 162
Obesity-related hypertension: possible pathophysiological mechanisms
Vaněčková, I., Maletı́nská, L., Behuliak, M., Pražienková, V., Zicha, J., & Kuneš, J. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0368 · Cited by 168
The role of the sympathetic nervous system in obesity-related hypertension
da Silva, A. A., do Carmo, J. M., Dubinion, J. H., & Hall, J. E. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0036-3 · Cited by 156
Self-citationObesity-Related Hypertension in Children
Brady, T. M. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00197 · Cited by 170
Leptin, obesity and cardiovascular disease
Correia, M., & Haynes, W. G. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200403000-00010 · Cited by 153
Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis
Rahmouni, K. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.00920 · Cited by 150
Tallam, L. S., Stec, D. E., Willis, M. A., da Silva, A. A., & Hall, J. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000175474.99326.bf · Cited by 148
Self-citationSrinivasan, S. R., Myers, L., & Berenson, G. S. (2006) · Hypertension · doi:10.1161/01.hyp.0000226410.11198.f4 · Cited by 143
Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of Leptin
Tallam, L. S., da Silva, A. A., & Hall, J. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000227966.36744.d9 · Cited by 133
Self-citationObesity-hypertension: an ongoing pandemic
Francischetti, E. A., & Genelhu, V. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01262.x · Cited by 130
do Carmo, J. M., da Silva, A. A., Cai, Z., Lin, S., Dubinion, J. H., & Hall, J. E. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161349 · Cited by 127
Self-citationMaruyama, Y., Mizuguchi, M., Yaginuma, T., Kusaka, M., Yoshida, H., Yokoyama, K., Kasahara, Y., & Hosoya, T. (2008) · Spinal Cord · doi:10.1038/sj.sc.3102171 · Cited by 124
Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome
Correia, M. L. G., & Rahmouni, K. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00562.x · Cited by 121
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure
Lambert, É., Straznicky, N. E., Eikelis, N., Esler, M., Dawood, T., Masuo, K., Schlaich, M. P., & Lambert, G. W. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281053af4 · Cited by 123
Chapman, M. J., & Sposito, A. C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.004 · Cited by 123
A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity
Hilzendeger, A. M., Morgan, D. A., Brooks, L. A., Dellsperger, D., Liu, X., Grobe, J. L., Rahmouni, K., Sigmund, C. D., & Mark, A. L. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00974.2011 · Cited by 118
da Silva, A. A., Kuo, J. J., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000128421.23499.b9 · Cited by 117
Role of leptin in obesity‐related hypertension
Haynes, W. G. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2005.031237 · Cited by 117
Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Kuo, J. J., Silva, A. A., & Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000048194.97428.1a · Cited by 113
Self-citationLeptin and the Cardiovascular System
Rahmouni, K. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.225 · Cited by 110
Masuyama, H., Mitsui, T., Eguchi, T., Tamada, S., & Hiramatsu, Y. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00095.2016 · Cited by 114
Impact of the obesity epidemic on hypertension and renal disease
Hall, J. E., Jones, D. W., Kuo, J. J., da Silva, A. A., Tallam, L. S., & Liu, J. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0084-z · Cited by 106
Self-citationMendoza, J. M. G., Amador‐Licona, N., Flores-Martínez, S. E., López-Cardona, M. G., Ahuatzin-Trémary, R., & Sánchez‐Corona, J. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001824 · Cited by 109
Maternal obesity and the developmental programming of hypertension: a role for leptin
Taylor, P. D., Samuelsson, A., & Poston, L. (2014) · Acta Physiologica · doi:10.1111/apha.12223 · Cited by 103
Positive Relationship Between Plasma Leptin Level and Hypertension
Shankar, A., & Xiao, J. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148213 · Cited by 105
Obesity As a Risk Factor for Sustained Ventricular Tachyarrhythmias in MADIT II Patients
Pietrasik, G. M., Goldenberg, I., McNitt, S. A., Moss, A. J., & Zaręba, W. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00680.x · Cited by 106
Hypertension in Metabolic Syndrome: Vascular Pathophysiology
Mendizábal, Y., Llorens, S., & Nava, E. (2013) · International Journal of Hypertension · doi:10.1155/2013/230868 · Cited by 107
Masuyama, H., Mitsui, T., Nobumoto, E., & Hiramatsu, Y. (2015) · Endocrinology · doi:10.1210/en.2014-2020 · Cited by 104
Galletti, F., D’Elia, L., Barba, G., Siani, A., Cappuccio, F. P., Farinaro, E., Iacone, R., Russo, O., Palma, D. D., Ippolito, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1280 · Cited by 94
Lean heart: Role of leptin in cardiac hypertrophy and metabolism
Hall, M. E., Harmancey, R., & Stec, D. E. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i9.511 · Cited by 95
Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms
Parvanova, A. I., Reseghetti, E., Abbate, M., & Ruggenenti, P. L. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad282 · Cited by 104
Leptin and mechanisms of endothelial dysfunction and cardiovascular disease
Knudson, J. D., Payne, G. A., Borbouse, L., & Tune, J. D. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0082-2 · Cited by 90
Inflammatory Cytokines as Uremic Toxins: “Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son”
Castillo-Rodríguez, E., Pizarro-Sánchez, M. S., Sanz, A. B., Ramos, A. M., Sánchez-Niño, M. D., Martín-Cleary, C., Fernández‐Fernández, B., & Ortíz, A. (2017) · Toxins · doi:10.3390/toxins9040114 · Cited by 85
Mechanisms of hypertension in the cardiometabolic syndrome
Redón, J., Cífková, R., Laurent, S., Nilsson, P. M., Narkiewicz, K., Erdine, S. E., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831e13e5 · Cited by 86
Role of Perivascular Adipose Tissue in Vascular Physiology and Pathology
Cao, Z. F. H., Stoffel, E., & Cohen, P. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08451 · Cited by 87
Additive Effects of Maternal High Fat Diet during Lactation on Mouse Offspring
Masuyama, H., & Hiramatsu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092805 · Cited by 85
Sloan, C., Tuinei, J., Nemetz, K., Frandsen, J. E., Soto, J. E., Wride, N., Sempokuya, T., Alegria, L., Bugger, H., & Abel, E. D. (2011) · Diabetes · doi:10.2337/db10-1106 · Cited by 86
Mechanisms of endothelial dysfunction in obesity-associated hypertension
Lobato, N. S., Filgueira, F. P., Akamine, E. H., Tostes, R. C., de Carvalho, M. H. C., & Fortes, Z. B. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500058 · Cited by 84
Cardiovascular effects of leptin and orexins
Shirasaka, T., Takasaki, M., & Kannan, H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00359.2002 · Cited by 84
El-Atat, F. A., Aneja, A., McFarlane, S. I., & Sowers, J. R. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00070-7 · Cited by 83
Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients
Seravalle, G., Colombo, M., Perego, P., Giardini, V., Volpe, M., Dell’Oro, R., Mancia, G., & Grassi, G. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02988 · Cited by 80
da Silva, A. A., do Carmo, J. M., Kanyicska, B., Dubinion, J., Brandon, E., & Hall, J. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100636 · Cited by 79
Self-citationLeptin and cardiovascular diseases
Hou, N., & Luo, J. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05619.x · Cited by 79
Lambert, É., Straznicky, N. E., Sari, C. I., Eikelis, N., Hering, D., Head, G. A., Dixon, J. B., Esler, M., Schlaich, M. P., & Lambert, G. W. (2012) · American Journal of Hypertension · doi:10.1093/ajh/hps016 · Cited by 77
Neurons of the Rostral Ventrolateral Medulla Contribute to Obesity-Induced Hypertension in Rats
Stocker, S. D., Meador, R., & Adams, J. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000254828.71253.dc · Cited by 77
Relationship between Plasma Leptin Level and Chronic Kidney Disease
Shankar, A., Syamala, S., Xiao, J., & Muntner, P. (2012) · International Journal of Nephrology · doi:10.1155/2012/269532 · Cited by 76
Obesity and chronic kidney disease.
Eknoyan, G. (2011) · PubMed · doi:10.3265/nefrologia.pre2011.may.10963 · Cited by 74
Leptin Impairs Cardiovagal Baroreflex Function at the Level of the Solitary Tract Nucleus
Arnold, A. C., Shaltout, H. A., Gallagher, P. E., & Diz, D. I. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138065 · Cited by 71
Krause, M. D. S., Bock, P. M., Takahashi, H., de Bittencourt, P. I. H., & Newsholme, P. (2015) · Clinical Science · doi:10.1042/cs20140695 · Cited by 71
Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation
Kuo, J. J., da Silva, A. A., Tallam, L. S., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000111836.54204.93 · Cited by 68
Self-citationBelin de Chantemèle, E. J., Muta, K., Mintz, J., Tremblay, M. L., Marrero, M. B., Fulton, D. J., & Stepp, D. W. (2009) · Circulation · doi:10.1161/circulationaha.109.853077 · Cited by 67
Obesity-Induced Hypertension: Brain Signaling Pathways
do Carmo, J. M., da Silva, A. A., Wang, Z., Fang, T., Aberdein, N., Rodriguez, C. E. P. D. L., & Hall, J. E. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0658-1 · Cited by 67
Self-citationObesity, diabetes, and chronic kidney disease
Eknoyan, G. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0076-5 · Cited by 75
Role of Perivascular Adipose Tissue in Health and Disease
Fernández‐Alfonso, M. S., Somoza, B., Tsvetkov, D., Kuczmanski, A., Dashwood, M. R., & Gil‐Ortega, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170004 · Cited by 71
Role of leptin and central nervous system melanocortins in obesity hypertension
da Silva, A. A., Carmo, J. M. D., & Hall, J. E. (2013) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32835d0c05 · Cited by 63
Self-citationLeptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease
Alix, P. M., Guebre‐Egziabher, F., & Soulage, C. O. (2014) · Biochimie · doi:10.1016/j.biochi.2014.06.024 · Cited by 65
Metabolic syndrome and chronic kidney disease
Ruan, X. Z., & Guan, Y. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00042.x · Cited by 61
Glia, sympathetic activity and cardiovascular disease
Marina, N., Teschemacher, A. G., Kasparov, S., & Gourine, A. V. (2016) · Experimental Physiology · doi:10.1113/ep085713 · Cited by 60
The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances
Hill, J. W., & Faulkner, L. D. (2016) · Neuroendocrinology · doi:10.1159/000450649 · Cited by 57
Role of adipokines in obesity‐associated hypertension
Vlasova, M. A., Purhonen, A., Järvelin, M., Rodilla, E., Pascual, J., & Herzig, K. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02171.x · Cited by 53
Adipose-Vascular Coupling and Potential Therapeutics
Gollasch, M. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104542 · Cited by 51
da Silva, A. A., Tallam, L. S., Liu, J., & Hall, J. E. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00187.2006 · Cited by 51
Self-citationMetabolic Syndrome: The Constellation of Co-morbidities, A Global Threat
Madan, K., Paliwal, S., Sharma, S. K., Kesar, S., Chauhan, N., & Madan, M. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230309144825 · Cited by 55
Raimundo, M. R., & Lopes, J. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/747861 · Cited by 54
da Silva, A. A., Kuo, J. J., Tallam, L. S., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000111139.94378.74 · Cited by 49
Self-citationThe Brain Melanocortin System, Sympathetic Control, and Obesity Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Physiology · doi:10.1152/physiol.00061.2013 · Cited by 47
Self-citationdo Carmo, J. M., Hall, J. E., & da Silva, A. A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00265.2008 · Cited by 47
Self-citationda Silva, A. A., do Carmo, J. M., Freeman, J. N., Tallam, L. S., & Hall, J. E. (2009) · Diabetes · doi:10.2337/db08-1221 · Cited by 47
Self-citationObesity-related hypertension: Is there a role for selective leptin resistance?
Correia, M. L. G., & Haynes, W. G. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0074-9 · Cited by 46
Metadata
- Authors
- Carlyle, M., Jones, O. B., Kuo, J. J., & Hall, J. E.
- Affiliations
- University of Mississippi Medical Center (US)
- Venue
- Hypertension
- Published
- 2002-02
- Volume
- 39
- Issue
- 2
- Pages
- 496-501
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2072436009
- Cited by
- 292
- References
- 22
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 6 · 2022: 13 · 2021: 11 · 2020: 8 · 2019: 13 · 2018: 4 · 2017: 21 · 2016: 21 · 2015: 13 · 2014: 18 · 2013: 10 · 2012: 16
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- National Heart, Lung, and Blood Institute (P01-HL-51971, P01HL051971)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- leptin, adrenergic activity, alpha-blockers, beta-blockers, terazosin, propranolol, blood pressure, heart rate, dietary intake, insulin, glucose regulation, glomerular filtration rate, obesity, sympathetic nervous system
- MeSH terms
- Adrenergic Agonists, Animals, Blood Pressure, Disease Models, Animal, Drug Interactions, Eating, Heart Rate, Hormones, Kidney, Kidney Function Tests, Male, Pressoreceptors, Receptors, Adrenergic, Tachycardia, Rats, Sprague-Dawley, Adrenergic Antagonists, Leptin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
